Pathological diagnosis of liver cell adenoma, hepatocellular adenoma (HCA), and focal nodular hyperplasia (FNH) is discussed. HCA is a rare tumor, presenting in a variety of clinical settings, which cannot be identified conclusively by any currently available imaging technique. FNH has been reported in 0.6-3% of the general population and is 10 times more frequently observed than adenomas in referral centers. The examination of a liver biopsy or resection specimen remains the standard practice to establish the diagnosis of HCA and FNH when radiographic investigations have failed to establish a definitive diagnosis. The optimal care of patients with liver nodule requires the combined expertise of hepatologists, pathologists, radiologists, and surgeons. development of more readily available immunobiological tools will permit significant improvements in the liver biopsy interpretation in the ability to distinguish HCA and FNH.

Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia : Bordeaux update / P. Bioulac-Sage, C. Balabaud, P. Bedossa, J.Y. Scoazec, L. Chiche, A.P. Dhillon, L. Ferrel, V.P.T. Roskems, V. Vilgrain, I.R. Wanless, J. Zucman-Rossi, M. Roncalli, Laennec Group, the Elves Group. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 2007:46(2007), pp. 521-527.

Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia : Bordeaux update

M. Roncalli;
2007

Abstract

Pathological diagnosis of liver cell adenoma, hepatocellular adenoma (HCA), and focal nodular hyperplasia (FNH) is discussed. HCA is a rare tumor, presenting in a variety of clinical settings, which cannot be identified conclusively by any currently available imaging technique. FNH has been reported in 0.6-3% of the general population and is 10 times more frequently observed than adenomas in referral centers. The examination of a liver biopsy or resection specimen remains the standard practice to establish the diagnosis of HCA and FNH when radiographic investigations have failed to establish a definitive diagnosis. The optimal care of patients with liver nodule requires the combined expertise of hepatologists, pathologists, radiologists, and surgeons. development of more readily available immunobiological tools will permit significant improvements in the liver biopsy interpretation in the ability to distinguish HCA and FNH.
Settore MED/08 - Anatomia Patologica
2007
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/34828
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 158
  • ???jsp.display-item.citation.isi??? 120
social impact